Clinical Trial Update: Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3) [Phase 4]

View source ↗

Summary

Phase 4 trial update focused on simplifying pangenotypic HCV treatment and retreatment strategies in Rwanda and similar settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Partners in Health | Conditions: Hepatitis C, Chronic | Phase 4 | Status: UNKNOWN